Halozyme Therapeutics shares owned by Wellesley Investment Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Wellesley Investment Advisors
from 13F filings
Historical chart of Wellesley Investment Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Wellesley Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Wellesley Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $48B | 48M | 1003.38 |
| 2024-06-30 | $49B | 51M | 957.24 |
| 2024-03-31 | $48B | 54M | 887.26 |
| 2023-12-31 | $53B | 61M | 872.36 |
| 2023-09-30 | $55B | 64M | 858.47 |
| 2023-06-30 | $50B | 60M | 840.62 |
| 2023-03-31 | $60B | 71M | 853.69 |
| 2022-12-31 | $75M | 77k | 969.67 |
| 2022-09-30 | $76M | 89k | 855.48 |
| 2022-06-30 | $82M | 92k | 888.81 |
| 2022-03-31 | $64M | 71k | 890.60 |
More positions owned by Wellesley Investment Advisors
View all positions for Wellesley Investment Advisors